HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
March 31st, 2019
7.8K views
A CRISPR/sgRNA library has been applied to interrogating protein-coding genes.However, the feasibility of a sgRNA library to uncover the function of a CTCF boundary in gene regulation remains unexplored. Here, we describe a HOX loci specific sgRNA library to elucidate the function of CTCF boundaries in HOX loci.
Overview
This study explores the use of a HOX loci specific sgRNA library to investigate the role of CTCF boundaries in gene regulation. The approach aims to enhance understanding of noncoding elements and their impact on HOX gene expression.
Key Study Components
Area of Science
- Gene regulation
- CRISPR technology
- HOX gene function
Background
- CTCF is a key regulator of chromatin structure and gene expression.
- Understanding CTCF boundaries can provide insights into gene regulation mechanisms.
- HOX genes play critical roles in development and disease.
- Previous studies have not fully explored the impact of CTCF on HOX loci.
Purpose of Study
- To elucidate the function of CTCF boundaries in HOX gene regulation.
- To assess the feasibility of using an sgRNA library for this purpose.
- To investigate the implications for early embryonic development and leukemias.
Methods Used
- Design of sgRNA targeting CTCF binding sites.
- Cloning of the sgRNA library into cell preparations.
- Packaging of lentivirus using HEK293 T cells.
- Screening for effects on gene expression.
Main Results
- Successful design and implementation of a HOX loci specific sgRNA library.
- Identification of the role of CTCF in regulating HOX gene expression.
- Insights into the function of noncoding elements in gene regulation.
- Potential applications in understanding leukemias with aberrant HOX signatures.
Conclusions
- The study demonstrates the utility of sgRNA libraries in gene regulation research.
- CTCF boundaries significantly influence HOX gene expression.
- Findings may have broader implications for developmental biology and cancer research.
Frequently Asked Questions
What is the significance of CTCF in gene regulation?
CTCF is crucial for maintaining chromatin structure and regulating gene expression by forming boundaries that influence enhancer-promoter interactions.
How does the sgRNA library work?
The sgRNA library allows for targeted disruption of specific genomic sites to study their functional roles in gene regulation.
What are HOX genes?
HOX genes are a group of related genes that control the body plan of an embryo along the head-tail axis and are essential for proper development.
What potential applications do the findings have?
The findings can help in understanding developmental processes and the mechanisms underlying certain cancers associated with HOX gene dysregulation.
What methods were used to package the lentivirus?
Lentivirus was packaged by cotransfecting HEK293 T cells with specific plasmid vectors for the sgRNA library and envelope proteins.
Can this approach be applied to other genes?
Yes, the sgRNA library approach can be adapted to study other genes and regulatory elements beyond HOX loci.
Executive Industry Relevance
Disrupting CTCF-mediated chromatin boundaries in HOX loci enables functional interrogation of noncoding regulatory elements that drive oncogenic gene expression in leukemia models. This approach supports target validation by linking specific boundary elements to disease-relevant transcriptional outputs, providing mechanistic de-risking for therapeutic hypotheses involving chromatin architecture. The sgRNA library screening strategy offers a scalable method to prioritize regulatory elements with predictive confidence in preclinical target selection.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Identifies CTCF boundary elements as critical regulators of HOXA9 expression in MLL-rearranged AML models.
- Operational Value: Enables pooled screening of noncoding elements to functionally annotate genetic regulatory regions in disease contexts.
- Scientific Value: Links chromatin boundary disruption to oncogenic chromatin domain formation and ectopic HOX gene expression patterns.
Screening & Assay Development
- Scientific Value: Generates quantitative HOXA9 expression readouts via RT-qPCR to assess phenotypic impact of sgRNA-mediated boundary disruption.
- Operational Value: Uses nuclease digestion and heteroduplex analysis to validate indel mutations at targeted CTCF sites with single-clone resolution.
- Scientific Value: Confirms genotype-phenotype correlation by Sanger sequencing of sgRNAs in clones showing >50% HOXA9 reduction.
Translational & Preclinical Research
- Scientific Value: Demonstrates relevance of CTCF boundaries in maintaining leukemogenic HOX expression signatures, supporting preclinical target prioritization.
- Operational Value: Provides a reusable screening platform for annotating noncoding elements in disease-relevant genomic loci beyond HOX clusters.
- Scientific Value: Supports mechanistic de-risking by validating causal roles of specific boundary elements in disease-associated gene dysregulation.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by enabling systematic functional screening of noncoding regulatory elements, with outputs informing lead identification and preclinical validation decisions in chromatin-modifying target programs.
- Discovery Biology: Supports hypothesis testing of chromatin boundary function in gene regulation through pooled genetic screening.
- Screening: Delivers assay-ready clonal lines with validated sgRNA integration and quantifiable HOXA9 expression changes.
- Analytics: Generates quantitative PCR-based expression data and genotyping outputs to correlate genetic perturbations with phenotypic effects.
- Translational Research: Connects boundary element function to leukemogenic phenotypes in MLL-rearranged AML models, enabling risk-adjusted advancement.
- Enterprise Reuse: Establishes a adaptable lentiviral sgRNA library framework for screening regulatory elements in other disease-associated loci.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through mechanistic linkage of noncoding elements to oncogenic gene expression.
- Operational Value: Standardized workflow for lentiviral delivery, clonal isolation, and molecular validation of sgRNA effects.
- Strategic Value: Informs go/no-go decisions by reducing ambiguity in regulatory element function prior to therapeutic investment.
- Portfolio Impact: Enables risk-adjusted prioritization of chromatin architecture targets based on functional validation in disease models.
Implementation Considerations
- Requires expertise in lentiviral production, CRISPR screening, and molecular cloning for library generation and validation.
- Dependent on HEK293T cells for viral packaging and MOLM13 cells for screening in AML models.
- Necessitates standardized puromycin selection and clonal dilution methods to isolate single-cell-derived populations.
- Relies on RT-qPCR, Sanger sequencing, and nuclease digestion assays for on-target validation and mutation detection.
- Limited by transfection efficiency and MOI optimization to ensure representative library coverage and avoid clonal bias.
Biopharma FAQs
Why does disrupting CTCF boundaries matter for target validation in HOX loci?
Disrupting CTCF boundaries enables functional assessment of their role in constraining oncogenic chromatin interactions and maintaining ectopic HOX gene expression in leukemia models. This approach links specific boundary elements to measurable transcriptional outputs, supporting target validation through genotype-phenotype correlation. It provides mechanistic insight into how chromatin architecture contributes to disease-relevant gene dysregulation.
How does isolating the CBS7/9 variable fit the discovery pipeline for leukemia targets?
Isolating the CTCF binding site between HOXA7 and HOXA9 (CBS7/9) identifies a specific noncoding element whose deletion reduces HOXA9 expression in MLL-rearranged AML models. This variable isolation enables de-risking of therapeutic hypotheses by linking a defined genomic locus to a disease-relevant phenotypic output. It supports early discovery prioritization by validating causal roles of boundary elements in leukemogenic gene expression programs.
What quantitative measurements of HOXA9 expression enable target prioritization?
RT-qPCR measurement of HOXA9 levels provides a quantitative readout to assess the phenotypic impact of sgRNA-mediated CTCF boundary disruption. Clones showing >50% reduction in HOXA9 expression were selected for further validation, establishing a threshold for functional significance. This quantitative output enables comparison across conditions and supports data-driven target prioritization in preclinical screening.
Why do replication requirements matter for cross-functional collaboration in chromatin screening?
Replication across multiple independent clones (e.g., HOXA9-decreased clones 5, 6, 28, and 121) strengthens confidence that observed phenotypes are due to on-target effects at the CBS7/9 boundary. Consistent indel mutation detection via nuclease digestion and genotyping across replicates reduces false-positive rates in screening data. This reproducibility enables reliable handoff between discovery, assay development, and translational teams for target validation.
What statistical analysis capabilities are required before implementing this screening approach?
Implementation requires capabilities to quantify gene expression changes (e.g., RT-qPCR), detect indel mutations (e.g., nuclease digestion assays), and validate sgRNA integration (e.g., Sanger sequencing). These analytical outputs must be correlated to establish genotype-phenotype links with statistical rigor. Access to clonal quantification and mutation validation tools is essential to ensure screening data supports reliable target prioritization decisions.
Chapters in this video
0:04
Title
0:49
The High Titer sgRNA Library Lentivirus Generation
1:44
Titration of Lentiviral Library in MOLM13 Leukemia Cells
2:59
Transduction of the Pooled CRISPR-Cas9 KO Library
4:20
Screening of the Pooled CRISPR-Cas9 KO Library with One-Step RT-qPCR
5:41
Verification of Integrated sgRNAs Positive Clones through Genotyping and Sanger Sequence
6:37
Detection of sgRNAs Induced Indel Mutation by Nuclease Digestion Assay
7:48
Results: Pooled CRISPR-Cas9 KO Library Screening and Identification
9:19
Conclusion
